跳至主要内容
临床试验/IRCT20211031052922N1
IRCT20211031052922N1招募中3 期

Evaluation of the effectiveness of medroxyprogesterone on blood gases and short term hospital outcomes in patients with Chronic Obstructive Pulmonary Disease (COPD) exacerbation who received Non Invasive Ventilation (NIV)

Esfahan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 80 years(—)
性别
All

入选标准

  • Chronic Obstructive Pulmonary Disease (COPD) exacerbation patients who has one of this criteria(dyspnea, increased sputum volume, and a change in the nature of sputum)
  • COPD exacerbation patient who needs Non Invasive Ventilation (NIV)
  • Age between 30-80
  • Signing the written informed consent

排除标准

  • Requiring mechanical ventilation by the time of admission
  • Having a current or history of thromboembolic diseases like Pulmonary Thrombosis Embolie (PTE), active thrombophelebitis, Deep Vein Thrombosis (DVT)
  • History of cerebrovascular disease, history of myocardial infarction (MI) and stroke
  • Unexplained vaginal bleeding
  • Hepatic diseases
  • History of breast cancer or any estrogen or progesterone dependent tumors
  • History of allergy to hormonal drugs containing progesterone
  • Stable and frequent vomiting
  • Decreased level of consciousness
  • Deformity or trauma in face

研究者

相似试验